BostonGene
BostonGene's mission is to power healthcare's transition to personalized medicine using our AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics. BostonGene Tumor PortraitTM Testsreveal key drivers of each tumor, including immune microenvironment properties, actionable mutations, biomarkers of response to diverse therapies, and recommended therapies. Through these comprehensive analyses, BostonGene Tumor PortraitTM Tests generate a personalized roadmap for therapeutic decision-making for each cancer patient.
Last updated on
About BostonGene
Founded
2015Estimated Revenue
$10M-$50MEmployees
251-1KFunding / Mkt. Cap
$200MCategory
Sector
Information TechnologyIndustry Group
Software & ServicesIndustry
SoftwareSIC Code
73NAICs Code
51Location
City
WalthamState
MassachusettsCountry
United StatesBostonGene
Find your buyer within BostonGene